ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.
What is Thermogenesis Holdings Inc (THMO)'s P/E Ratio?
The P/E ratio of Thermogenesis Holdings Inc is 0
Who is the CEO of Thermogenesis Holdings Inc?
Dr. Xiaochun Xu is the Chairman of the Board of Thermogenesis Holdings Inc, joining the firm since 2016.
What is the price performance of THMO stock?
The current price of THMO is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Thermogenesis Holdings Inc?
Thermogenesis Holdings Inc belongs to Health Care industry and the sector is Health Care
What is Thermogenesis Holdings Inc market cap?
Thermogenesis Holdings Inc's current market cap is $NaN
Is Thermogenesis Holdings Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Thermogenesis Holdings Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell